Article Details

Atara Biotherapeutics (NASDAQ:ATRA) Research Coverage Started at Roth Capital

Retrieved on: 2019-09-22 20:56:15

Tags for this article:

Click the tags to see associated articles and topics

Atara Biotherapeutics (NASDAQ:ATRA) Research Coverage Started at Roth Capital. View article details on hiswai:

Excerpt

<div>Finally, <b>Baupost Group</b> LLC MA raised its position in shares of Atara Biotherapeutics by 9.7% during the 2nd quarter. <b>Baupost Group</b> LLC MA now ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo